Global Longlife Hospital & Research Share Price Today | Stock Price & Global Longlife Hospital & Research Share Screener
Track the current Global Longlife Hospital & Research share price and stock price live with TickJournal's free stock screener. Check GLHRL annual price range for the annual price range and momentum. Use the Global Longlife Hospital & Research stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Global Longlife Hospital & Research opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Over the trailing twelve months the company reported revenue of ₹24 and net income of ₹2, with EBITDA of ₹4, an operating margin of 9.0% and a profit margin of 8.3%.
Global Longlife Hospital & Research Share Price Chart
Track the current stock price of Global Longlife Hospital & Research with an interactive chart. Analyse GLHRL share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Global Longlife Hospital & Research stock quote in one place.
Global Longlife Hospital & Research Company Profile - Fundamental Screener
Screen Global Longlife Hospital & Research company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for GLHRL shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Healthcare Services sector and the Hospitals industry, and it trades under ISIN INE0J2K01014.
Company Details
Classification
Identifiers and Leadership
Global Longlife Hospital & Research Balance Sheet Screener
Screen GLHRL balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2026, total assets were ₹24, down from ₹27 in 2025.
Latest statistics put total assets at ₹24 and shareholder funds at ₹24.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
Assets |
||||||||
| Total Assets | 24 | 27 | 42 | 76 | 34 | 37 | 42 | 43 |
| Current Assets | 20 | 23 | 4 | 34 | 11 | 12 | 16 | 15 |
| Fixed Assets | 0 | 0 | 17 | 17 | 17 | 18 | 19 | 20 |
Liabilities |
||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 0 | 0 | 4 | 4 | 3 | 13 | 17 | 18 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Shareholders' Equity |
||||||||
| Total Equity | 24 | 27 | 26 | 64 | 17 | 14 | 12 | 12 |
| Share Capital | 11 | 11 | 11 | 11 | 7 | 7 | 7 | 7 |
| Reserves & Surplus | 13 | 16 | 15 | 54 | 10 | 7 | 5 | 5 |
Global Longlife Hospital & Research Income Statement Screener - Profit & Revenue Analysis
Screen Global Longlife Hospital & Research income statement and profit fundamentals. Analyze GLHRL quarterly results. Global Longlife Hospital & Research reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For None-None, revenue was ₹24 and net profit was ₹2, equal to earnings per unit of ₹1.80, at an operating margin of 9%.
In that period expenses were ₹19, interest cost ₹0 and tax ₹1. The next period listed, 2026-March, shows revenue of ₹0 and net profit of ₹-2.
| Item | None-None | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March |
|---|---|---|---|---|---|---|---|---|---|
Revenue and Expenses | |||||||||
| Revenue | 24 | 0 | 6 | 14 | 24 | 33 | 33 | 34 | 35 |
| Expenses | 19 | 1 | 5 | 14 | 20 | 25 | 27 | 30 | 28 |
Operating Costs and Margins | |||||||||
| EBITDA | 4 | -1 | 1 | 0 | 4 | 8 | 6 | 4 | 7 |
| Operating Profit % | 9.00% | 0.00% | -720.00% | -2.00% | 17.00% | 24.00% | 17.00% | 10.00% | 20.00% |
| Depreciation | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 2 | 2 |
| Interest | 0 | 0 | 0 | 1 | 0 | 1 | 2 | 2 | 2 |
Profit and Earnings | |||||||||
| Profit Before Tax | 3 | -1 | 0 | -2 | 3 | 6 | 2 | -1 | 3 |
| Tax | 1 | 1 | 0 | 0 | 1 | 2 | 0 | 0 | 1 |
| Net Profit | 2 | -2 | 0 | -2 | 2 | 4 | 2 | -1 | 1 |
| EPS | 1.80 | -1.64 | 0.19 | -2.08 | 1.79 | 5.11 | 2.92 | -1.23 | 1.95 |
Global Longlife Hospital & Research Cash Flow Screener - Liquidity Fundamentals
Screen GLHRL cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2026-March, operating activities used ₹5, and net cash flow was an outflow of ₹5.
Over the same period, investing activities provided ₹0 and financing activities provided ₹0.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March |
|---|---|---|---|---|---|---|---|---|
Cash from Operations and Investing | ||||||||
| Operating Activities | -5 | 12 | -5 | -40 | 9 | 7 | 4 | 5 |
| Investing Activities | 0 | 22 | -1 | -2 | 0 | 0 | 0 | 0 |
Financing and Net Cash | ||||||||
| Financing Activities | 0 | -13 | 3 | 46 | -10 | -7 | -3 | -5 |
| Net Cash Flow | -5 | 21 | -3 | 3 | 0 | 0 | 1 | 0 |
Global Longlife Hospital & Research Shareholding Pattern Screener
See Global Longlife Hospital & Research shareholding pattern with promoter, FII, and DII holdings. Check Global Longlife Hospital & Research promoter holding and ownership changes for GLHRL on TickJournal, and see how institutional stock price moves affect the market.
In 2026-Mar, promoters held 22.88%, foreign institutions 0.00%, domestic institutions 0.00% and the public 57.21%, spread across 1,149 shareholders.
The shareholder count was 1,149 in 2026-Mar, compared with 1,133 in 2026-Jun.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
Promoter Holding | ||||||||
| Promoter Holding | 22.88% | 22.88% | 54.29% | 54.90% | 55.10% | 35.44% | 54.29% | 54.29% |
Institutional Investors | ||||||||
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Government, Public and Others | ||||||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 57.21% | 56.32% | 33.71% | 33.20% | 33.31% | 53.48% | 37.13% | 34.62% |
| Other Holding | 19.91% | 20.80% | 12.00% | 11.90% | 11.59% | 11.09% | 8.58% | 11.10% |
| Shareholder Count | 1,149 | 1,133 | 938 | 917 | 915 | 985 | 947 | 1,010 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Global Longlife Hospital & Research. Global Longlife Hospital & Research dividend yield can be compared with peers and other stocks in the market.
Global Longlife Hospital & Research Stock Index Membership - Nifty & Sensex
See which indices include Global Longlife Hospital & Research stock. Check GLHRL index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
Complete Index List
Global Longlife Hospital & Research Market Events Screener - Corporate Actions
Get Global Longlife Hospital & Research corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Global Longlife Hospital & Research stock events that may affect GLHRL share price, along with derivatives, futures and options activity and sector gainers.
8 corporate actions are listed, the most recent entry being Annual General Meeting dated June 25, 2026, with a record date of June 25, 2026.
It is followed by Quarterly Result Announcement dated May 7, 2026 and Quarterly Result Announcement dated November 12, 2025.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-06-25 | 2026-06-25 | Annual General Meeting | NA | -20.70% |
| 2026-05-07 | 2026-05-07 | Quarterly Result Announcement | NA | 4.19% |
| 2025-11-12 | 2025-11-12 | Quarterly Result Announcement | NA | 7.42% |
| 2025-08-29 | 2025-08-29 | Annual General Meeting | NA | -8.48% |
| 2025-04-28 | 2025-04-28 | Quarterly Result Announcement | NA | 4.65% |
| 2024-10-28 | 2024-10-28 | Quarterly Result Announcement | NA | -9.89% |
| 2024-09-27 | 2024-09-27 | Annual General Meeting | NA | -14.58% |
| 2024-05-14 | 2024-05-14 | Extraordinary General Meeting | NA | -7.58% |
Global Longlife Hospital & Research Competitors Screener - Peer Stocks Comparison
Screen GLHRL competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the Healthcare Services sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Apollo Hospitals | 124,503 | 58.67 | 25,420 | 15.58% | 2,003 | 43.13 |
| Max Healthcare Institute | 95,582 | 66.86 | 8,536 | 18.82% | 1,442 | 36.74 |
| Aster DM Quality Care | 63,976 | 179.76 | 4,769 | 11.25% | 427 | 36.84 |
| Fortis Healthcare | 62,058 | 58.65 | 9,179 | 16.93% | 1,064 | 25.57 |
| Global Health | 38,047 | 69.81 | 4,509 | 19.56% | 554 | 44.47 |
| Narayana Hrudayalaya | 36,579 | 45.50 | 7,996 | 43.43% | 811 | 38.14 |
| Krishna Institute of Medical Sciences | 32,336 | 165.49 | 3,931 | 28.16% | 242 | 45.36 |
| Dr. Agarwal's Health Care | 15,699 | 86.39 | 2,125 | 20.92% | 168 | 44.18 |
| Rainbow Childrens Medicare | 13,891 | 48.05 | 1,747 | 11.49% | 282 | 31.72 |
| Park Medi World | 11,898 | 40.25 | 1,711 | 19.99% | 274 | 41.32 |
Global Longlife Hospital & Research Company Announcements - News & Reports Screener
Screen GLHRL latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
20 recent announcements are listed, the latest dated October 5, 2026.
The next most recent announcements are dated October 3, 2026 and August 25, 2026.
| Date | Update | Actions |
|---|---|---|
| 2026-10-05 | Intimation Regarding Alteration In Name Of The Company Pursuant To Approval Of Registrar Of Companies | - |
| 2026-10-03 | Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011 | - |
| 2026-08-25 | Alteration In Objects Clause Of The Company. | - |
| 2026-08-19 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-08-13 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-08-10 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-08-03 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2026-07-24 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-06-26 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-06-26 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-06-26 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-06-26 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | - |
| 2026-06-25 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |
| 2026-06-02 | Reg. 34 (1) Annual Report. | - |
| 2026-06-02 | Notice Of 15Th Annual General Meeting Of The Company To Be Held On June 25 2026 At 11:00 AM IST Through VC/OAVM. | - |
| 2026-05-30 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-05-30 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-05-30 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-05-30 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-05-30 | Board Meeting Outcome for Adoption Of Notice Of 15Th AGM Board Report Appointment Of Auditors And Other Matters. | - |
Frequently Asked Questions
How is the company valued right now?
The P/E ratio is -8.34 and the P/B ratio is 0.60, with earnings per unit of ₹-1.64. Market capitalisation stands at ₹13.68 Cr. The company operates in the Healthcare Services sector, in the Hospitals industry, so compare these ratios with its sector peers in the table above.
About This Data
Key statistics were last updated on October 6, 2026. This page covers 8 balance sheet periods, 9 income statement periods, 8 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.